SCHEMBL5449286

SCHEMBL5449286

NC(=O)c1c(NC(=O)NC2CC2)sc2c1CCC(O)C2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.55
MAPT P10636 4/20 0.52
DUSP3 P51452 1/20 0.52
PTPN5 P54829 1/20 0.52
PTPN11 Q06124 1/20 0.52
ANO1 Q5XXA6 1/20 0.50
TNIK Q9UKE5 1/20 0.49
ALDH1A1 P00352 5/20 0.48
RAB9A P51151 3/20 0.48
NPC1 O15118 2/20 0.48
POLB P06746 1/20 0.48
AIP O00170 1/20 0.48
SGTA O43765 1/20 0.48
TOMM70 O94826 1/20 0.48
STIP1 P31948 1/20 0.48
PPP5C P53041 1/20 0.48
DNAJC7 Q99615 1/20 0.48
STUB1 Q9UNE7 1/20 0.48
FLT3 P36888 2/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5454129 0.94 PTPN1 (0.52) PTPN1MAPTDUSP3PTPN5PTPN11
SCHEMBL5456030 0.86 MAPT (0.70) MAPTDUSP3PTPN5PTPN11ANO1
SCHEMBL5453397 0.83 PTPN1 (0.53) PTPN1MAPTDUSP3PTPN5PTPN11
SCHEMBL5455042 0.82 FLT3 (0.70) PTPN1MAPTDUSP3PTPN5PTPN11
SCHEMBL5451302 0.82 FLT3 (0.70) PTPN1MAPTDUSP3PTPN5PTPN11
SCHEMBL5752965 0.81 TNIK (0.74) PTPN1MAPTDUSP3PTPN5PTPN11
SCHEMBL5459994 0.81 TNIK (0.74) PTPN1MAPTDUSP3PTPN5PTPN11
SCHEMBL5446149 0.81 TNIK (0.74) PTPN1MAPTDUSP3PTPN5PTPN11
SCHEMBL5458911 0.81 AIP (0.58) PTPN1MAPTDUSP3PTPN5PTPN11
SCHEMBL5453345 0.79 TNIK (0.59) PTPN1MAPTDUSP3PTPN5PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents GPC BIOTECH AG (DE) 2007-11-29 US claimed
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents GPC BIOTECH AG (DE) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents TBCA, PARK7, NFATC1 PTPN1 2192/4885MAPT 21/4885DUSP3 110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.